Recruiting

Transdiagnostic Cognitive Biomarkers

The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as…

ClinicalTrials.gov IDNCT04864080
PhaseNA
Enrollment48
SponsorUniversity of Minnesota
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Pain, Depression

About this study

The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.

Interventions

Primary outcomes

Eligibility information

Arm 1, healthy controls: Inclusion Criteria: * Have access to the online study platform. Exclusion Criteria: * under 18, non-English speaking Arm 2: pain and depression: Inclusion Criteria: * Pain or depression Exclusion Criteria: * pregnant women

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.